Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Finding Trial of PEG 3350 Plus Electrolytes for Constipation
NCT01212445Phase 2Completed
- Sponsor
- Bayer
- Start
- Oct 2010
- Primary completion
- Nov 2011
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of polyethylene glycol in constipation (3 arms), sponsored by Bayer. Primary endpoint: Percentage of Participants With Successful Bowel Movement (BM) Within 24 Hours of PEG + E Administration. Started Oct 2010; status: completed.
02
Drugs
polyethylene glycol
03
Conditions
constipation
Beyond the preview
Go deeper on NCT01212445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01212445.